By Business/Source
Currency:USD
2026/Q1
Stock NameRevenueRatio
Lymphedema products62.22M82.67%
Airway clearance products13.05M17.33%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States329.52M100.00%